Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical ...
News Medical on MSN12d
Omalizumab treats multi-food allergy better than oral immunotherapyThe high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Academically, socially, and institutionally, America has not yet recovered from COVID-19 on the fifth anniversary of ...
Medical Xpress on MSN12d
Omalizumab treats multi-food allergy better than oral immunotherapy, study findsM.D., M.P.H., director of NIH's National Institute of Allergy and Infectious Diseases (NIAID), the study's funder and ...
Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.
10d
Verywell Health on MSNFood Allergy vs. Intolerance: How to Tell the DifferenceFood allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results